# Phase 16 Route B Readiness Review

**Date:** 2026-06-03
**Status:** NOT APPROVED - Exploratory analysis only

## Executive Summary

Phase 16 has made significant progress in data exploration and baseline table generation. However, **no artifacts are ready for Route B approval** at this time. All outputs remain exploratory and require further validation.

## Current State Assessment

### What Has Been Completed

| Phase | Status | Key Achievement |
|-------|--------|-----------------|
| P14 | ✅ Complete | Raw data ingested locally |
| P15 | ✅ Complete | MIDUS parsed, 17 baseline tables |
| P16 | ✅ Complete | NLSY97 dictionary extracted, cross-wave analysis |

### What Has NOT Been Completed

| Requirement | Status | Blocker |
|-------------|--------|---------|
| Variable validation | Partial | NLSY97 needs value label extraction |
| Model cards | Not started | Required for Route B |
| Statistical validation | Not started | Required for Route B |
| Cross-source harmonization | Not started | Required for Route B |
| Production ML integration | Not started | Explicitly blocked |

## Route B Readiness Criteria

### Must Have (Not Yet Met)

1. **✅ Variable confirmation:** MIDUS data_confirmed, NLSY97 data_confirmed via header
2. **❌ Value label extraction:** Response codes not mapped to labels
3. **❌ Statistical validation:** No hypothesis testing or effect sizes
4. **❌ Model cards:** No documentation of intended use, limitations, risks
5. **❌ Cross-source validation:** No comparison of MIDUS vs NLSY97 patterns
6. **❌ Sensitivity analysis:** No robustness checks

### Should Have (Not Yet Met)

1. **❌ Multiple imputation:** Missingness not properly handled
2. **❌ Confidence intervals:** Not computed for baseline tables
3. **❌ Subgroup analysis:** No demographic breakdowns
4. **❌ Temporal trends:** Cross-wave patterns not validated

## What Exists Now

### Useful Descriptive Priors

- MIDUS baseline tables (17 aggregate tables)
- NLSY97 baseline tables (12 aggregate tables)
- Cross-wave comparison (descriptive only)
- Missingness audit (aggregate)

### These Are NOT Ready For

- ❌ Production forecasting
- ❌ Personal probability generation
- ❌ Route B approval
- ❌ Clinical or decision-making use

## Specific Artifacts Assessment

### MIDUS Baseline Tables (P15)

| Artifact | Status | Ready for Route B? |
|----------|--------|-------------------|
| self_rated_health | Aggregate | No - needs validation |
| life_satisfaction | Aggregate | No - 10-20% missing |
| neuroticism | Aggregate | No - 10-20% missing |
| perceived_mastery | Aggregate | No - 10-20% missing |
| demographics | Aggregate | No - descriptive only |

### NLSY97 Baseline Tables (P16)

| Artifact | Status | Ready for Route B? |
|----------|--------|-------------------|
| demographics | Sample only | No - needs validation |
| education | Sample only | No - needs value labels |
| employment | Sample only | No - needs value labels |
| financial | Sample only | No - needs value labels |

### Cross-Wave Analysis (P16)

| Analysis | Status | Ready for Route B? |
|----------|--------|-------------------|
| Descriptive comparison | Complete | No - not causal |
| Attrition patterns | Not modeled | No |
| Cohort effects | Not controlled | No |

## What Must Happen Before Route B

### Phase 17 Requirements

1. **Value label extraction:** Map all response codes to labels
2. **Statistical validation:** Compute effect sizes, confidence intervals
3. **Model cards:** Document intended use, limitations, risks
4. **Cross-source validation:** Compare MIDUS vs NLSY97 patterns
5. **Sensitivity analysis:** Test robustness to missing data handling

### Phase 18+ Requirements

1. **Multiple imputation:** Handle missing data properly
2. **Subgroup analysis:** Demographic breakdowns
3. **Temporal modeling:** Longitudinal patterns (if linkage confirmed)
4. **External validation:** Compare with other datasets
5. **Peer review:** Independent statistical review

## Safety Confirmations

✅ **No production ML added** - Only descriptive statistics  
✅ **No Route B approval granted** - All artifacts exploratory  
✅ **No personal probabilities emitted** - Only aggregate statistics  
✅ **No raw data committed** - All raw data gitignored  
✅ **No individual-level data in artifacts** - Aggregate only  

## Conclusion

**Phase 16 artifacts are useful descriptive priors but require substantial validation before Route B consideration.** The current outputs provide a foundation for future analysis but should NOT be used for:

- Production forecasting
- Personal probability generation
- Clinical or decision-making support
- Any application requiring statistical rigor

## Next Steps

1. **Phase 17:** Value label extraction + statistical validation
2. **Phase 18:** Model cards + cross-source validation
3. **Phase 19:** Multiple imputation + sensitivity analysis
4. **Phase 20:** External validation + peer review

**Route B approval is NOT recommended at this time.**
